Growing up in Tijuana, Mexico, Olivia Graeve was interested in pursuing the sciences but didn’t quite know how to...
San Diego Union-TribuneThe company taps signal processing techniques from cellular communications to boost the number of biological targets detected for researchers
San Diego Union-Tribune/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a strategic research...
Endpoints NewsShares of Illumina Inc. shed 1.29% to $203.53 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...
Endpoints NewsMany corporations and companies have adopted employee resource groups, or ERGs, into their work cultures to help employees from minority and marginalized backgrounds feel welcome and to provide career support and development.
In a twist of events, PureTech and Nektar said the media frenzy around their merger talks has pushed them to call things off for now. London-based PureTech put out a release last week disclosing it “has exchanged indicative, non-binding proposals with Nektar Therapeutics” regarding a possible combin…
Endpoints News| October 11, 2022
The computational chemistry experts at Nimbus have always taken pride in selecting compelling targets and deploying a structure-based approach to drug them. Eli Lilly is now swooping in to partner on one such target. In a $496 million deal — which covers research funding as well as milestones — Lill…
Endpoints NewsShares of Illumina Inc. slid 3.07% to $206.18 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...
ReportLinkerThe Bioinformatics Market is predicted to reach US$ ~83.94 billion by 2031 from US$ ~22.24 billion in 2020, and to grow at a CAGR of ~14.2% between the
Global Agrigenomics Market, By Purpose (DNA Extraction & Purification, DNA/RNA Sequencing, Genotyping, Gene Expression Profiling, GMO/Trait Purity Testing,...
Illumina CEO Francis deSouza told analysts that the company can cut sequencing’s cost without crimping its 60%-plus gross margins.
There is more to the comparison, and in the sections below, we discuss why we believe ILMN stock will offer better returns than TMO stock in the next three years.
EIN PresswireIllumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2022 following the close of market on Thursday, November 3, 2022.
Many corporations and companies have adopted employee resource groups, or ERGs, into their work cultures to help employees from minority and marginalized backgrounds feel welcome and to provide career support and development. These groups are completely voluntary and employee-led, and unite employee…
Shares of Illumina Inc. shed 2.65% to $212.72 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...
EIN PresswireIllumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 19.07% on an annualized basis producing an average annual return of 26.54%. Currently, Illumina has a market capitalization of $33.48 billion.
EIN PresswireNext Generation Sequencing (NGS) is a high-throughput DNA sequencing technology that separates billions or millions of DNA strands and sequence in parallel,
Shares of Illumina Inc. rallied 6.56% to $218.52 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...
GEN - Genetic Engineering and Biotechnology News/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ILMN, TWTR, AAPL, NKE, and HES. Click a link below then choose between in-depth options...
GEN - Genetic Engineering and Biotechnology News
